STI
31
3
PYPL
60
-2
GOOGL
67
8
NTAP
61
-6
KMI
65
-4
NDAQ
52
2
RHI
57
-2
AVGO
35
-9
DE
56
-2
DG
27
4
SHW
55
-3
COP
40
-4
CNX
71
2
ZTS
54
-4
XRAY
46
2
DNB
60
2
ADI
57
-3
TRV
42
-6
SYK
59
2
CTSH
52
-3
STI
31
3
PYPL
60
-2
GOOGL
67
8
NTAP
61
-6
KMI
65
-4
NDAQ
52
2
RHI
57
-2
AVGO
35
-9
DE
56
-2
DG
27
4
SHW
55
-3
COP
40
-4
CNX
71
2
ZTS
54
-4
XRAY
46
2
DNB
60
2
ADI
57
-3
TRV
42
-6
SYK
59
2
CTSH
52
-3
Financhill
Back

Tango Therapeutics Quote, Financials, Valuation and Earnings

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE
Buy
54

TNGX
Tango Therapeutics

Last Price:
3.10
Seasonality Move:
0.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Tango Therapeutics Price Quote

$3.10
-0.21 (-6.34%)
(Updated: December 11, 2024 at 5:55 PM ET)

Tango Therapeutics Key Stats

Buy
54
Tango Therapeutics (TNGX) is a Buy
Day range:
$3.09 - $3.42
52-week range:
$2.70 - $13.01
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.19
P/B ratio:
1.55%
Volume:
1.1M
Avg. volume:
2.7M
1-year change:
-63.94%
Market cap:
$355.6M
Revenue:
$36.5M
EPS:
$-1.16

How Much Does Tango Therapeutics Make?

Is Tango Therapeutics Growing As A Company?

  • What Is Tango Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Tango Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Tango Therapeutics Stock Price Performance

What Is Tango Therapeutics 52-Week High & Low?

Tango Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Tango Therapeutics?

Is Tango Therapeutics Cash Flow Positive?

  • What Is TNGX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$122.3M
  • What Is Tango Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $48.2M
  • What Is Tango Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $67.9M

Tango Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TNGX return on invested capital is -48.54%
  • What Is Tango Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -31.31%
  • What Is TNGX Return On Equity?
    ROE is a measure of profitability and is -48.54%

Tango Therapeutics Earnings Date & Stock Price

Tango Therapeutics Competitors

Tango Therapeutics Dividend Yield

Tango Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 27.94%
Revenue: 8.15% 43.9%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.50
Upside from Last Price: 247.43%

Major Shareholders

  • How many TNGX shares are owned by institutional investors?
    168.2M TNGX shares are owned by institutional investors
  • How many TNGX shares are owned by insiders?
    2.1M TNGX shares are owned by insiders